A randomized, controlled, multicenter, open-label clinical trial of the efficacy and safety of B cell depletion followed by daratumumab in the treatment of autoimmune encephalitis

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 3c39e72bcd53ab5e9433151d618b796d2ae1acd6
First added on: Mar 22, 2025